Combination Therapy of HIV Using Fusion/Entry Inhibitors Targeting GP41
    6.
    发明申请
    Combination Therapy of HIV Using Fusion/Entry Inhibitors Targeting GP41 有权
    使用针对GP41的融合/抑制剂组合治疗HIV

    公开(公告)号:US20100040631A1

    公开(公告)日:2010-02-18

    申请号:US12540325

    申请日:2009-08-12

    IPC分类号: A61K39/42 A61K38/00

    摘要: Provided herein are pharmaceutical compositions for the prophylactic and therapeutic treatment of HIV comprising combinations of HIV fusion/entry inhibitors with different target sites in HIV gp41 or different mechanisms of action. Also disclosed are methods of treating HIV infection by administering such compositions.

    摘要翻译: 本文提供了用于预防和治疗HIV的药物组合物,其包含HIV融合/进入抑制剂与HIV gp41中不同靶位点或不同作用机制的组合。 还公开了通过施用这样的组合物治疗HIV感染的方法。

    Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors
    9.
    发明授权
    Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors 有权
    人类免疫缺陷病毒(HIV)融合抑制剂的高效协同组合

    公开(公告)号:US07919101B2

    公开(公告)日:2011-04-05

    申请号:US12540325

    申请日:2009-08-12

    IPC分类号: A61K39/21

    摘要: Provided herein are pharmaceutical compositions for the prophylactic and therapeutic treatment of HIV comprising combinations of HIV fusion/entry inhibitors that exhibit synergistic effect, including T-20 (enfuvirtide), T-1249, T-1144, C34, and sifuvirtide. Also disclosed are methods of treating HIV infection by administering such compositions.

    摘要翻译: 本文提供了用于预防和治疗HIV的药物组合物,其包含具有协同作用的HIV融合/进入抑制剂的组合,包括T-20(恩夫韦肽),T-1249,T-1144,C34和西夫韦特。 还公开了通过施用这样的组合物治疗HIV感染的方法。

    Bifunctional Molecules for Inhibiting HIV Entry
    10.
    发明申请
    Bifunctional Molecules for Inhibiting HIV Entry 有权
    用于抑制HIV进入的双功能分子

    公开(公告)号:US20090298774A1

    公开(公告)日:2009-12-03

    申请号:US12474105

    申请日:2009-05-28

    IPC分类号: A61K38/16 C07K14/00 A61P31/18

    CPC分类号: C07K14/005 C12N2740/16122

    摘要: Disclosed herein are bifunctional molecules which inhibit HIV entry into the target cell. Also disclosed are novel anti-HIV therapeutics for treatment of patients infected by HIV, including non-B and multi-drug resistant strains.

    摘要翻译: 本文公开了抑制HIV进入靶细胞的双功能分子。 还公开了用于治疗感染HIV的患者的新型抗HIV治疗剂,包括非B型和多重耐药性菌株。